[Form 4] Enova International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

David Fisher, Chief Executive Officer and Director of Enova International, Inc. (ENVA), reported option exercises and subsequent share sales on September 17 and September 19, 2025. Mr. Fisher exercised option rights at an exercise price of $23.96 to acquire 35,000 shares on 09/17/2025 and 6,000 shares on 09/19/2025. On the same dates he sold 35,000 shares (weighted-average sale price $125.5488) and 6,000 shares (weighted-average sale price $125.8924), respectively. The filings disclose the sales were executed in multiple trades at specified price ranges and note that the sale(s) were effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan. Following these transactions, Mr. Fisher’s reported beneficial ownership is 348,223 shares.

Positive

• Exercise and sale executed with clear disclosure including weighted-average prices and execution ranges
• Sales effected under Rule 10b5-1 trading plan, indicating preplanned compliance with insider trading rules
• Significant realized gain implied by exercise price of $23.96 and sale prices around $125.55–$125.89

Negative

• Insider sold 41,000 shares (35,000 on 09/17/2025 and 6,000 on 09/19/2025), reducing reported beneficial ownership to 348,223 shares
• Form 4 does not disclose the exact per-trade quantities and prices for each individual trade within the reported ranges (only weighted averages and ranges are provided)

Insights

Securities Analyst

TL;DR: CEO exercised options at $23.96 and sold 41,000 shares at ~ $125.55–$125.89, realizing substantial gains; final holding 348,223 shares.

These transactions are routine option exercises paired with open-market sales. The exercise price of $23.96 compared with weighted-average sale prices above $125 indicates a large intrinsic gain per share realized by the reporting person. The Form 4 discloses multiple-trade execution ranges and confirms use of a Rule 10b5-1 plan for the sale, which supports preplanned compliance with insider trading rules. For investors, the material facts are the sizes, prices, and resultant ownership level of 348,223 shares.

Corporate Governance Expert

TL;DR: Insiders exercised long-dated options and sold shares under a 10b5-1 plan; disclosures appear complete with trade ranges provided.

The Form 4 includes the grant/exercise structure (options with limited SARs) and details on vesting and SAR exercise conditions. Providing weighted-average prices and ranges, and stating the sale was effected pursuant to a 10b5-1 plan, aligns with strong disclosure practice. The filing also explains the tandem nature of options and SARs and the vesting schedule. No governance or compliance shortfalls are evident from the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fisher David

(Last) (First) (Middle)

C/O ENOVA INTERNATIONAL, INC.

175 W. JACKSON BOULEVARD, SUITE 600

(Street)

CHICAGO IL 60604

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Enova International, Inc. [ ENVA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/17/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock, par value $0.00001 per share	09/17/2025		M		35,000	A	$23.96	383,223	D
Common stock, par value $0.00001 per share	09/17/2025		S		35,000	D	$125.5488(1)	348,223	D
Common Stock, par value $0.00001 per share	09/19/2025		M		6,000	A	$23.96	354,223	D
Common Stock, par value $0.00001 per share	09/19/2025		S(2)		6,000	D	$125.8924(3)	348,223	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy) with limited SAR(4)(5)	$23.96	09/17/2025		M			35,000	(6)	02/12/2026	Common stock; par value $0.00001 per share	35,000	$0	80,562	D
Non-Qualified Stock Option (right to buy) with limited SAR(4)(5)	$23.96	09/19/2025		M			6,000	(6)	02/12/2026	Common stock; par value $0.00001 per share	6,000	$0	74,562	D

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $123.75 to $127.89. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

2. The sale reported in this Form 4 was effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

3. This transaction was executed in multiple trades at prices ranging from $124.8055 to $127.23. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer full information regarding the number of shares and the prices at which the transaction was effected.

4. The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.

5. The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.

6. The options vested in substantially equal one-third increments on each of the following dates: February 12, 2020, February 12, 2021, and February 12, 2022.

	/s/ Sean Rahilly, as attorney in fact	09/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did ENVA insider David Fisher report on Form 4?

The Form 4 reports option exercises acquiring 35,000 shares on 09/17/2025 and 6,000 shares on 09/19/2025, followed by sales of 35,000 and 6,000 shares on those dates.

At what prices were the ENVA shares sold by David Fisher?

The weighted-average sale prices reported are $125.5488 for the 09/17/2025 sale and $125.8924 for the 09/19/2025 sale; execution ranges are provided in the filing.

Were the sales by the ENVA insider preplanned?

Yes. The filing states the sale(s) were effected pursuant to Mr. Fisher's Rule 10b5-1 trading plan.

How many ENVA shares does David Fisher beneficially own after these transactions?

Following the reported transactions, Mr. Fisher's beneficial ownership is reported as 348,223 shares.

What option terms or related instruments are disclosed in the Form 4?

The filing discloses non-qualified stock options with an exercise price of $23.96 granted in tandem with limited stock appreciation rights (SARs), with vesting completed in February 2020–2022 and expiration referenced as 02/12/2026.